Friends! In this video, I'm going to do an Amazon stock analysis and talk about the risks and upside potential of AMZN stock.
1 extracted signal · 1 resolved · 0 still active
The Patient Investor04 Aug 2025, 17:44 UTC
AI-generated source summary
The analyst reviews Amazon's Q2 2025 earnings report, noting an earnings per share of $1.68 versus the estimated $1.33 and revenue of $167.7 billion versus the estimated $162.09 billion. Amazon Web Services revenue grew 18%, trailing Microsoft Azure and Google Cloud. The advertising revenue grew 23% year-over-year. Guidance for the third quarter is set at $174 billion to $179.5 billion. The analyst notes that the stock went down 8.5% on the day and explores the decrease in the growth of cash flow from operations. After looking at a forward price to operating cash flow which at is at 14.2, analyst infers Amazon is still undervalued and infers a target of $250, setting a fail bound below $190, monitoring the future results.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
